Industry Perspectives

Phenomenex launches Endrix Long Life LC column for extended performance and durability

Designed for complex sample matrices, Endrix Long Life LC helps laboratories reduce downtime and improve reproducibility from method development through routine analysis.
Written byPhenomenex
| 1 min read
Image of the new Endrix Long Life LC Columns.

credit: Phenomenex 

Register for free to listen to this article
Listen with Speechify
0:00
1:00

TORRANCE, Calif., June 1, 2026 -- Phenomenex Inc., a Danaher Company and a global leader in the research and manufacture of advanced technologies for the separation sciences, today introduced the Endrix Long Life LC column, a new liquid chromatography solution engineered for extended column lifetime and consistent performance in demanding analytical workflows.

Designed to withstand challenging sample matrices and rigorous method conditions, Endrix Long Life LC helps laboratories move from method development to reproducible results with fewer interruptions. This latest advancement in Phenomenex's column hardware technology is purpose built for laboratories seeking to reduce downtime, improve throughput, and increase return on investment without sacrificing chromatographic performance.

"Scientists are under constant pressure to deliver high quality data while managing increasing sample complexity and tighter timelines," said Eric Lavold, Vice President for Product Management and Strategy at Phenomenex. "Endrix Long Life LC was developed to address these challenges directly by delivering exceptional durability and reliable performance over extended use."

Endrix Long Life LC offers a robust column design to help protect against common mechanisms of column failure, including peak distortion, pressure rise from build-up, and performance drift. By prioritizing column longevity and consistency from the start, Phenomenex enables laboratories to maintain method integrity across longer analytical campaigns. These capabilities make Endrix Long Life LC columns well-suited for pharmaceutical and clinical laboratories, forensic and toxicology laboratories, and environmental and food testing laboratories where method reliability is critical.

The product will be officially unveiled at the 73rd ASMS Conference on Mass Spectrometry and Allied Topics (ASMS 2026) and attendees can explore application data and discuss Endrix best practices with Phenomenex specialists at booth 802.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

Here are some related topics that may interest you:

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

3D illustration of a membrane protein embedded within a lipid nanodisc, representing a native-like environment used for membrane protein stabilization and characterization.
Mass photometry supports membrane protein characterization by providing rapid insights into sample composition, purity, and molecular assembly.
3D illustration of a protein complex composed of clustered spherical subunits arranged in a ring-like oligomeric structure, shown in shades of blue, cyan, and purple against a blue gradient background.
Automated mass photometry helps reveal the complex dynamics of protein oligomerization and the factors that govern protein assembly.
Illustration of translucent Y-shaped antibodies floating in a soft blue and green background, representing antibody research, development, and biomedical science.
Explore how antibody accessibility and custom development strategies can influence the pace and success of translational research.
Drug Discovery News December 2025 Issue
Latest IssueVolume 21 • Issue 4 • December 2025

December 2025

December 2025 Issue

Explore this issue